CJC-1295 with DAC and Pancragen Interaction

Monitor
Mechanism-based 47% confidence

CJC-1295 with DAC and Pancragen have an interaction requiring monitoring for interaction with 47% confidence. Both CJC-1295 with DAC and Pancragen affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). These compounds primarily affect different organ systems.

Compound Profiles

CJC-1295 with DAC

Long-Acting Growth Hormone Releasing Hormone Analog | Extended Release

DAC binds to albumin, extending half-life to 6-8 days and providing continuous GHRH receptor stimulation for sustained GH/IGF-1 elevation..

Half-life: 6-8 days Typical dose: 1-2mg weekly growth hormone, weight loss
ghrh receptorigf1 carcinogenic riskestrogenicinsulin disrupting
View full profile

Pancragen

KEDW Tetrapeptide | Pancreas Bioregulator

Pancragen works through epigenetic regulation by interacting with chromatin complexes and DNA structures to modulate pancreatic gene expression. Research shows it upregulates critical transcription factors for pancreatic cell maturation including Pdx1, Pax6, Ptf1a, Foxa2, Nkx2.

Half-life: Not established Typical dose: 10-20mg daily longevity, metabolic
insulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds affect insulin sensitivity (CJC-1295 with DAC, Pancragen). Monitor fasting glucose and HbA1c.

Frequently Asked Questions

Can I take CJC-1295 with DAC with Pancragen?

Yes, but with caution. Both CJC-1295 with DAC and Pancragen affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). Regular monitoring is advised.

Is CJC-1295 with DAC and Pancragen safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: insulin disrupting. Monitor accordingly.

What are the interactions between CJC-1295 with DAC and Pancragen?

Both CJC-1295 with DAC and Pancragen affect insulin sensitivity or blood glucose. Monitor fasting glucose and HbA1c. Consider adding an insulin sensitizer (metformin/berberine). This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 with DAC and Pancragen?

CJC-1295 with DAC has a half-life of 6-8 days and Pancragen has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: CJC-1295 with DAC vs Pancragen

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.